1. Home
  2. PGEN vs REAL Comparison

PGEN vs REAL Comparison

Compare PGEN & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.58

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$8.87

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
REAL
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
PGEN
REAL
Price
$3.58
$8.87
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
$8.33
$17.00
AVG Volume (30 Days)
4.2M
3.8M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.55
EPS
N/A
N/A
Revenue
$230,981,000.00
$692,845,000.00
Revenue This Year
$1,115.92
$14.30
Revenue Next Year
$81.04
$10.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.38
52 Week Low
$1.38
$4.71
52 Week High
$5.47
$17.39

Technical Indicators

Market Signals
Indicator
PGEN
REAL
Relative Strength Index (RSI) 36.15 36.42
Support Level $3.49 $8.69
Resistance Level $3.64 $12.87
Average True Range (ATR) 0.27 0.52
MACD -0.08 -0.03
Stochastic Oscillator 7.39 4.40

Price Performance

Historical Comparison
PGEN
REAL

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About REAL The RealReal Inc.

The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.

Share on Social Networks: